Dr David J. Adams

University of Sydney

David is a geneticist whose mission is to develop and study animal models of human disease. During his PhD research David realised the limitations of studies performed on human subjects and decided to commence post-doctoral studies at the Wellcome Trust Sanger Institute, Cambridge, where he employed embryonic stem cell technology to modify the genome of the mouse. These mice, known as ‘knockout mice’, can be engineered to develop diseases such as cancer and heart disease, and are like ‘mini-humans’.